Ubs Asset Management Americas Inc Arvinas, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $417 Billion
  • Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 433,531 shares of ARVN stock, worth $7.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
433,531
Previous 430,484 0.71%
Holding current value
$7.94 Million
Previous $10.6 Million 21.62%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$17.83 - $28.04 $54,328 - $85,437
3,047 Added 0.71%
433,531 $8.31 Million
Q3 2024

Nov 14, 2024
SELL
$23.66 - $32.73 $16,372 - $22,649
-692 Reduced 0.16%
430,484 $10.6 Million
Q2 2024

Aug 13, 2024
BUY
$24.46 - $40.4 $5.79 Million - $9.56 Million
236,680 Added 121.69%
431,176 $11.5 Million
Q1 2024

May 15, 2024
SELL
$36.38 - $52.31 $1.39 Million - $1.99 Million
-38,121 Reduced 16.39%
194,496 $8.03 Million
Q4 2023

Feb 14, 2024
BUY
$14.19 - $42.33 $1.02 Million - $3.04 Million
71,911 Added 44.75%
232,617 $9.57 Million
Q3 2023

Nov 13, 2023
SELL
$19.64 - $28.21 $17,047 - $24,486
-868 Reduced 0.54%
160,706 $3.16 Million
Q1 2023

May 15, 2023
SELL
$26.15 - $37.26 $159,907 - $227,844
-6,115 Reduced 3.65%
161,574 $4.41 Million
Q4 2022

Feb 14, 2023
BUY
$32.47 - $57.24 $294,567 - $519,281
9,072 Added 5.72%
167,689 $5.74 Million
Q3 2022

Nov 14, 2022
BUY
$41.87 - $57.99 $4.5 Million - $6.23 Million
107,473 Added 210.14%
158,617 $7.06 Million
Q2 2022

Aug 12, 2022
BUY
$36.01 - $74.24 $191,825 - $395,476
5,327 Added 11.63%
51,144 $2.15 Million
Q1 2022

May 16, 2022
BUY
$60.27 - $81.57 $147,360 - $199,438
2,445 Added 5.64%
45,817 $3.08 Million
Q4 2021

Feb 14, 2022
BUY
$65.85 - $96.21 $63,347 - $92,554
962 Added 2.27%
43,372 $3.56 Million
Q3 2021

Nov 15, 2021
SELL
$73.2 - $107.87 $117,120 - $172,592
-1,600 Reduced 3.64%
42,410 $3.49 Million
Q2 2021

Aug 16, 2021
BUY
$60.45 - $84.26 $676,858 - $943,459
11,197 Added 34.12%
44,010 $3.39 Million
Q1 2021

May 14, 2021
BUY
$58.19 - $91.37 $513,526 - $806,340
8,825 Added 36.79%
32,813 $2.17 Million
Q4 2020

Mar 01, 2021
SELL
$20.19 - $84.93 $3.32 Million - $13.9 Million
-164,219 Reduced 87.25%
23,988 $2.04 Million
Q3 2020

Nov 13, 2020
SELL
$22.99 - $36.34 $6.24 Million - $9.87 Million
-271,576 Reduced 59.07%
188,207 $4.44 Million
Q2 2020

Aug 14, 2020
BUY
$29.88 - $56.74 $4.55 Million - $8.65 Million
152,413 Added 49.59%
459,783 $15.4 Million
Q1 2020

May 15, 2020
BUY
$33.0 - $54.5 $9.95 Million - $16.4 Million
301,370 Added 5022.83%
307,370 $12.4 Million
Q4 2019

Feb 14, 2020
BUY
$15.39 - $44.38 $92,340 - $266,280
6,000 New
6,000 $246,000

Others Institutions Holding ARVN

# of Institutions
224
Shares Held
70.9M
Call Options Held
1.53M
Put Options Held
346K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $974M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email